Premas Biotech and Oramed announce oral COVID-19 vaccine candidate that produces antibodies after a single dose

Premas Biotech, a developer of novel biotherapeutic and vaccine candidates, announced today the development of an oral COVID-19 vaccine that has shown efficacy after a single dose, in conjunction with Oramed Pharmaceuticals Inc. …